Hello and welcome back to The Kable for the last time this week. As always, today’s edition is packed with all things research, regulation and investment from the life sciences world. And as with all Fridays, today’s Kable is free. So send it to all your colleagues and friends who haven't realised what a brilliant resource we are; show them what they’re…
💉 Investigating India’s Galentic Pharma; Ending AIDS by 2030; Making generic TB drugs
#384 | Continue to drink your diet cola; Stay away from deer; Paint the town white
